Nursing · Independent exam preparation
Neurovascular Registered Nurse (NVRN) Board Certification Examination Study Guide
Practise acute stroke assessment, imaging decisions, treatment surveillance, complication prevention and evidence appraisal for the NVRN nursing examination.
By CertMedbry · Updated 28 October 2026
Practise distinguishing disabling stroke findings, selecting the next diagnostic question, recognizing treatment complications and matching prevention to stroke mechanism. This selective 60-concept guide covers all eight NVRN blueprint domains, with greatest emphasis on assessment and diagnosis. The official NVRN Exam Blueprint defines the full examination scope; these clinical topics are an editorial study selection, not an issuer-published subtopic list.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and credential does this guide address?
The Neurovascular Registered Nurse (NVRN) Board Certification Examination is offered through the Neurovascular Clinicians Certification Corporation (NVC-3). NVRN-BC is the resulting credential suffix, not a separate examination. ANVC describes its focus as acute neurovascular nursing.
How many questions are published, and how many are scored?
The official online blueprint states 200 questions. It does not specify how many are scored or whether any are unscored pretest questions. Do not assume that all 200 contribute to the examination score.
What duration and passing score are verified?
The cited issuer pages do not specify an examination duration or passing score. Consult current NVC-3 candidate instructions for those details before scheduling.
What delivery method, adaptivity and item styles are verified?
The NVC-3 page lists a 2026 in-person examination schedule. This does not establish every available delivery pathway, computer adaptivity or official item styles. The 20 four-option questions here are independent single-best-answer learning drills, not a reproduction of the examination interface or a pass prediction.
Which blueprint applies, and what is its effective date?
This guide uses the current issuer-linked online NVRN Exam Blueprint verified on October 11, 2026. It displays no revision number or effective date. The 2026 examination schedule and copyright footer do not establish a blueprint effective date.
How is the official blueprint weighted?
Assessment of Acute Clinical Neurovascular Findings: 18.5%; Diagnosis of Acute Neurovascular Disease: 18%; Acute Neurovascular Management: 14%; Pathophysiology & Pathogenesis of Neurovascular Disease: 14%; Secondary Stroke Prevention: 10%; Complication Avoidance & Management: 9%; Research Support for Acute Neurovascular Practice: 9%; Stroke Systems of Care: 7.5%. This guide approximates those weights with 11, 11, 8, 8, 6, 6, 5 and 5 concepts respectively. The official outline remains the full scope.
How does NVRN differ from the other certifications listed by NVC-3?
NVRN addresses registered nurses in acute neurovascular care. ANVP addresses advanced neurovascular practitioners, ASC addresses stroke coordinators, and CNIC addresses neurointerventional clinicians. These are separate certifications; their requirements and blueprints should not be substituted for NVRN preparation.
What nursing eligibility and jurisdiction information is published?
The certification page specifies registered nurse licensure in the applicant's country of origin and at least 1,000 hours of acute stroke clinical care during the preceding 12 months. It describes qualifying activities and a supervisor-attestation alternative for applicants below that hour threshold. Verify current application requirements with NVC-3. Clinical recommendations cited here include United States and Canadian sources; implementation follows applicable nursing authority and local stroke protocols.
This guide addresses registered nurses caring for hospitalized patients with acute neurovascular disease. It is independently authored educational material for the Neurovascular Registered Nurse examination and resulting NVRN-BC credential.
Outline used: Current issuer-linked NVRN Exam Blueprint, verified on 2026-10-11 (Asia/Hong_Kong). The published online blueprint specifies eight weighted domains and 200 questions but displays no revision number or effective date. The workbook label matches the official Neurovascular Registered Nurse examination; NVRN-BC denotes the resulting credential.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Assessment of Acute Clinical Neurovascular Findings18.5%
1.Why check glucose immediately in suspected stroke?
Hypoglycemia can produce focal weakness, altered speech or reduced consciousness that resembles stroke. A bedside glucose measurement identifies a rapidly treatable contributor while the stroke assessment continues. Correct an abnormal glucose promptly through the emergency pathway, then reassess the neurological findings. Persistent deficits after correction still require urgent stroke evaluation because a metabolic abnormality and cerebrovascular disease can coexist. Glucose measurement complements brain imaging; it cannot distinguish ischemia from hemorrhage.
Apply it
A patient develops sudden right arm weakness and confusion. Bedside glucose is markedly low. The nurse initiates the hypoglycemia protocol, maintains stroke activation and repeats the neurological examination after correction to determine whether focal deficits persist.
Common pitfall: Finding hypoglycemia does not establish that every neurological abnormality is metabolic. Stopping the stroke pathway before reassessment can miss concurrent ischemia or hemorrhage.
2.How is last-known-well different from discovery time?
Last-known-well is the most recent time the patient was known to be at their neurological baseline. Discovery time is when someone first noticed abnormal findings. These times can differ substantially, especially after sleep or an unwitnessed interval. Document both, identify the information source and clarify baseline deficits. Treatment assessment uses the relevant onset history together with imaging and eligibility criteria; discovery time must not silently replace an earlier last-known-well time.
Apply it
A spouse reports normal conversation at 22:00 and finds aphasia at 06:30. Record 22:00 as last-known-well and 06:30 as discovery, then obtain the history and imaging needed for an unknown-onset treatment assessment.
Common pitfall: Using the ambulance call time as onset can create a false treatment window. An unknown onset also does not automatically exclude every reperfusion pathway.
Emergency Medical Services Management of Acute Stroke Patients
3.Which medication details change an acute stroke assessment?
Medication history should identify anticoagulants, antiplatelets and the time of the most recent doses, rather than recording only that a patient takes a blood thinner. Drug identity, adherence, renal function and relevant coagulation testing can affect bleeding assessment, reversal decisions and reperfusion eligibility. Obtain collateral information when aphasia or impaired consciousness limits the interview. A medication list without timing is incomplete, and a normal routine coagulation result does not reliably exclude every direct oral anticoagulant effect.
Apply it
An aphasic patient carries a list containing dabigatran. The nurse asks family about the last dose, contacts the dispensing pharmacy when needed and communicates the drug, timing and available renal results during the stroke handover.
Common pitfall: Treating aspirin and an oral anticoagulant as interchangeable blood thinners obscures different mechanisms, laboratory interpretation and emergency treatment implications during acute stroke assessment.
4.How is arm drift assessed on the NIHSS?
The NIHSS arm motor item assesses each arm separately with palms down, held at 90 degrees when sitting or 45 degrees when supine for 10 seconds. Distinguish drift without reaching the support surface from an arm that falls to the surface, movement without antigravity effort and no movement. Use the instrument's standardized instructions rather than substituting grip strength. Position, duration and observed movement make serial scores interpretable across examiners.
Apply it
A supine patient raises the left arm to 45 degrees. It drifts downward during the 10-second observation but does not reach the bed. Document the standardized drift finding rather than describing only a weak handgrip.
Common pitfall: A strong grip does not establish normal proximal arm function. Changing arm position or observation time can produce misleading differences between repeated NIHSS examinations.
5.How does NIHSS leg testing differ from arm testing?
The NIHSS leg motor item is performed supine, testing each leg at 30 degrees for five seconds. The examiner distinguishes drift, falling to the bed, movement without sustained antigravity effort and absent movement. The shorter observation period and different elevation distinguish this item from arm testing. Apply the instrument's specific rules when amputation or joint fusion prevents testing, and describe relevant limitations so that an apparent score change is not mistaken for neurological deterioration.
Apply it
During reassessment, a patient's leg falls to the bed before five seconds despite initial antigravity movement. The nurse reports that specific change and compares it with the earlier standardized examination rather than relying on a general strength description.
Common pitfall: Testing legs for the arm item's 10 seconds changes the task. Pain or an orthopedic restriction also requires documentation rather than an unsupported neurological interpretation.
6.What distinguishes aphasia from impaired articulation?
Aphasia is impaired language processing or production, affecting naming, comprehension, repetition or meaningful expression. Dysarthria is impaired motor execution of speech. NIHSS language assessment uses picture description, naming and reading together with language observed throughout the examination. A patient can articulate clearly yet produce incorrect words or fail to understand commands. Determine what aspect of communication is impaired because language dysfunction can be disabling even when limb weakness is minimal.
Apply it
A patient speaks fluent, clearly articulated sentences containing incorrect words and cannot name common objects. The nurse identifies a language deficit, documents comprehension and naming findings, and communicates the functional impact during reperfusion assessment.
Common pitfall: Labeling every communication problem slurred speech can hide aphasia. Conversely, an unfamiliar language or hearing impairment should not automatically be scored as neurological language dysfunction.
7.How can dysarthria occur with preserved language?
Dysarthria changes speech clarity through impaired control of the muscles used for articulation. A patient may select appropriate words, follow commands and write meaningful answers while spoken words sound slurred. The NIHSS assesses articulation separately from language, using the designated word material or sufficient spontaneous speech when appropriate. Document mechanical barriers such as an endotracheal tube according to instrument instructions rather than assuming that an inability to speak proves severe dysarthria.
Apply it
A patient follows multistep conversation and writes an accurate description of a scene, but spoken words are consistently indistinct. Assess articulation separately, preserve the language findings and use an alternative communication method for immediate care needs.
Common pitfall: Assuming slurred speech means impaired comprehension can distort assessment and communication. A patient with dysarthria may understand complex explanations and retain decision-making ability.
8.What finding demonstrates sensory extinction?
Extinction occurs when a patient detects stimulation on either side individually but fails to report one side during simultaneous bilateral stimulation. This differs from primary sensory loss, in which unilateral stimulation itself is not perceived. The NIHSS extinction and inattention item also considers visual, tactile, spatial and personal neglect. Establish what the patient can detect individually before interpreting a bilateral trial, and integrate observed neglect rather than relying on one hurried test.
Apply it
A patient accurately reports touch to either hand alone. When both hands are touched together, only the right is reported. The nurse documents left tactile extinction and assesses other signs of inattention during the standardized examination.
Common pitfall: Failure to detect left-sided touch under every condition suggests primary sensory impairment rather than extinction alone. Simultaneous testing needs a reliable unilateral comparison first.
9.How do visual field loss and visual neglect differ?
Visual field loss is impaired detection within part of the visual field, whereas visual neglect reflects impaired attention to space despite potentially preserved elementary vision. Confrontation field testing and bilateral simultaneous stimulation explore different functions. A patient may have either deficit or both. The distinction matters for examination scoring and immediate safety: missing objects on one side can result from a field deficit, inattention or a combination, rather than poor cooperation.
Apply it
A patient misses left-sided stimuli even when presented alone. Another detects them singly but ignores them during bilateral presentation. Record the different findings and adapt room setup and supervision to each patient's demonstrated visual and attentional limitations.
Common pitfall: Calling every missed stimulus neglect bypasses field testing. A normal single-stimulus visual response also does not exclude extinction during competing bilateral stimulation at examination.
10.When does limb incoordination count as NIHSS ataxia?
The NIHSS limb ataxia item uses finger-to-nose and heel-to-shin testing to identify incoordination out of proportion to weakness. Failure caused entirely by paralysis is not evidence of ataxia. The examiner must distinguish an inaccurate trajectory from inability to generate the required movement. Standardized scoring therefore depends on the relationship between coordination and motor power, not merely whether the patient completes the task smoothly or reaches the target.
Apply it
A patient with near-normal strength repeatedly overshoots the target on finger-to-nose testing. Another cannot lift a profoundly paretic arm. Recognize demonstrable incoordination in the first patient without attributing the second patient's immobility to ataxia.
Common pitfall: Awarding ataxia points because a paralyzed limb cannot perform the maneuver double-counts weakness. Incoordination must be demonstrable beyond what the motor deficit explains.
11.How should NIHSS command performance be assessed?
For NIHSS item 1c, ask the patient to open and close the eyes, then grip and release the nonparetic hand. These are the two scored tasks. Substitute a suitable one-step command when the hands cannot be used; physical impediments such as trauma or amputation require appropriate task substitution. If the patient does not respond to the verbal command, demonstrate the task by pantomime and score the resulting performance. Give credit for an unequivocal attempt when weakness prevents completion. Score only the first attempt: 0 when both tasks are performed correctly, 1 when one is performed correctly, and 2 when neither is performed correctly.
Apply it
A patient has right hemiparesis and an intact left hand. Ask for eye opening and closing, then gripping and releasing with the left, nonparetic hand. Correct first-attempt performance of both tasks scores 0. If neither hand can be used because of bilateral injuries, substitute a suitable one-step command. An unequivocal attempt that cannot be completed because of weakness still receives credit.
Common pitfall: Do not select the paretic hand when the nonparetic hand is usable, count opening and closing the eyes as separate scored tasks, or replace the first attempt with a better response obtained through repeated coaching. Distinguish failure to follow a command from an unequivocal attempt limited by weakness.
Diagnosis of Acute Neurovascular Disease18%
12.What does immediate noncontrast brain CT establish?
Noncontrast CT rapidly identifies intracranial hemorrhage and other structural explanations for acute neurological symptoms. It is central to separating hemorrhagic from potentially ischemic stroke before treatments that increase bleeding risk. Early ischemic injury can be subtle or absent, depending on lesion size, location and time since onset. A scan without hemorrhage or visible infarction therefore does not exclude ischemic stroke. Persistent focal deficits require continued assessment, including arterial imaging when an occlusion is suspected, without waiting for a mature infarct to appear.
Apply it
Forty minutes after abrupt aphasia and right-sided weakness, CT shows neither hemorrhage nor a definite infarct. Communicate the persistent disabling findings and support urgent ischemic stroke treatment assessment and indicated vascular imaging.
Common pitfall: Interpreting an early scan without visible injury as proof against ischemia can delay treatment. Waiting for established infarction defeats the purpose of early assessment.
13.Why obtain vascular imaging during acute stroke evaluation?
CTA or another appropriate vascular study evaluates arteries for occlusion, stenosis or other vascular disease. Noncontrast CT primarily evaluates brain tissue and hemorrhage; it does not answer the same arterial question. Identifying an accessible large-vessel occlusion can change transfer and thrombectomy planning. Head and neck vascular assessment also informs stroke mechanism. Imaging selection should support time-sensitive decisions without creating avoidable delays in treatments for which the patient is already eligible.
Apply it
A patient with gaze deviation and dense hemiparesis has no hemorrhage on CT. The team obtains urgent arterial imaging to identify a possible large-vessel occlusion and determine whether an endovascular treatment pathway is needed.
Common pitfall: An initial brain scan without hemorrhage does not establish arterial patency. Conversely, a visible occlusion alone does not describe infarct extent or establish complete treatment eligibility.
14.What does diffusion-weighted MRI add after transient symptoms?
Diffusion-weighted MRI is more sensitive than noncontrast CT for many small acute ischemic lesions and is preferred when evaluating suspected TIA when available promptly. A diffusion-positive lesion indicates acute tissue injury despite symptom resolution and changes the event's diagnostic classification. Imaging complements the clinical history and vascular assessment. A negative diffusion study does not independently prove a benign mimic, especially when the symptom pattern remains strongly suggestive of transient focal cerebral ischemia.
Apply it
A patient's unilateral weakness resolves before arrival. CT shows no hemorrhage, but diffusion-weighted MRI demonstrates an acute matching lesion. Explain that recovery of function does not erase evidence of infarction and continue the stroke investigation.
Common pitfall: Equating symptom resolution with absence of tissue injury misses minor infarction. Equating a negative MRI with zero vascular risk is also an unsupported diagnostic shortcut.
15.Why do resolved focal symptoms still require urgent evaluation?
Transient focal neurological symptoms can signal an unstable vascular process and a near-term risk of completed stroke. Urgent evaluation seeks acute infarction, arterial disease and a cardiac source, while distinguishing plausible mimics. A reassuring current examination does not reveal what happened during the episode. The history should capture abruptness, specific deficits, duration and recovery. Clinical risk scores can support assessment, but they do not replace brain imaging, vascular evaluation or an appropriate urgent care pathway.
Apply it
A patient reports 15 minutes of sudden aphasia and right hand weakness but now examines normally. Arrange urgent TIA assessment with brain and vascular evaluation rather than treating the absence of current findings as diagnostic reassurance.
Common pitfall: A low risk score or normal examination can tempt premature discharge without adequate evaluation. Neither establishes that a transient focal episode was harmless or nonvascular.
16.How is symptomatic carotid disease distinguished from incidental stenosis?
A carotid lesion becomes a plausible symptomatic source when a recent retinal or hemispheric ischemic event matches the territory supplied by that artery. For example, left hemispheric aphasia with right-sided weakness can fit left carotid disease; isolated posterior circulation findings do not establish that relationship. Head and neck CTA can locate and quantify extracranial carotid narrowing, while brain imaging helps establish the injured territory. These findings support source attribution and intervention assessment, but stenosis on imaging alone cannot prove that the plaque caused the event.
Apply it
After a nondisabling left hemispheric stroke, CTA shows severe left extracranial carotid stenosis. Communicate the matching territory and measured severity for urgent specialist assessment, while preserving evaluation for competing embolic sources.
Common pitfall: Treating every detected carotid narrowing as symptomatic can lead to an unsupported intervention decision. Anatomical severity, symptom territory and competing causes must be considered together.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · Top Things to Know: 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Guideline
17.Why repeat brain imaging after deterioration in intracerebral hemorrhage?
Neurological deterioration after intracerebral hemorrhage may reflect hematoma expansion, intraventricular extension, hydrocephalus or increasing mass effect. Urgent reassessment and repeat brain imaging identify structural changes that can require immediate treatment. Compare consciousness, pupils and focal findings with the documented baseline while supporting physiological stability. Sedation, glucose abnormalities and other contributors should also be considered, but they do not justify delaying evaluation of a potentially expanding intracranial lesion.
Apply it
A patient with a known intracerebral hematoma becomes drowsier and develops new weakness. Escalate immediately, reassess vital and neurological findings, and prepare for urgent repeat imaging to evaluate expansion or another structural complication.
Common pitfall: Attributing new drowsiness to fatigue or the original stroke without reassessment can miss evolving hydrocephalus or hematoma expansion that was absent on initial imaging.
18.Which findings keep posterior circulation stroke under consideration?
Acute diplopia, dysarthria, severe gait or truncal instability and other brainstem or cerebellar findings can indicate posterior circulation ischemia. A low NIHSS total does not adequately exclude this pattern because some disabling posterior deficits contribute relatively few points. Evaluate the combination, timing and examination rather than treating isolated symptom labels as diagnostic. Appropriate brain and vascular imaging help answer whether infarction or vertebrobasilar arterial disease explains the presentation.
Apply it
A patient suddenly develops double vision, indistinct speech and inability to sit unsupported, with little limb weakness. Communicate the disabling posterior circulation pattern and support urgent stroke imaging despite a modest NIHSS total.
Common pitfall: Dismissing severe acute imbalance as benign vertigo solely because arm strength is preserved overlooks posterior circulation deficits. The total NIHSS is not a diagnostic exclusion test.
19.How do occlusion imaging and tissue imaging answer different questions?
Arterial imaging identifies where blood flow is obstructed, while brain tissue imaging assesses hemorrhage and ischemic injury. Perfusion or other advanced imaging may help selected treatment pathways estimate threatened tissue, but it does not replace the vascular question. A large-vessel occlusion and a small visible infarct can coexist early. Understanding these complementary roles helps explain why the team may request more than one imaging sequence without treating the studies as interchangeable.
Apply it
CTA shows a proximal arterial occlusion while noncontrast CT shows limited early injury. Explain that the arterial blockage and the current tissue changes are separate findings that must be integrated during urgent reperfusion assessment.
Common pitfall: A small visible lesion does not imply a small arterial problem. Likewise, locating an occlusion does not establish how much tissue remains viable or complete treatment eligibility.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
20.When should a possible stroke mimic be reconsidered?
Stroke evaluation includes checking for alternative explanations such as metabolic disturbance or seizure while maintaining attention to persistent focal findings. Correcting a plausible contributor is useful diagnostic information, but incomplete recovery requires continued reassessment. The diagnosis should follow the full temporal pattern, examination and imaging rather than the first abnormal test. A witnessed seizure also does not independently exclude stroke, because cerebrovascular injury can provoke seizure and produce an overlapping presentation.
Apply it
A patient has confusion after a witnessed seizure but also persistent unilateral weakness and an abrupt focal symptom history. Report both the seizure and focal deficit, and continue urgent evaluation rather than assuming a postictal explanation settles the diagnosis.
Common pitfall: Prematurely assigning a mimic diagnosis can delay treatment of concurrent stroke. Conversely, focal symptoms require evaluation rather than automatic treatment without imaging and eligibility assessment.
21.Why investigate cardiac rhythm after stroke or TIA?
Atrial fibrillation can be intermittent and may not appear on the first ECG. Identifying it can change the presumed stroke mechanism and the appropriate secondary prevention strategy. Initial cardiac assessment and indicated rhythm monitoring therefore address a cause that brain imaging cannot establish by itself. Interpret a normal brief recording as a sample of rhythm during that interval, not proof that paroxysmal atrial fibrillation has never occurred.
Apply it
A patient has an ischemic stroke without an established cause and a normal admission ECG. Explain why additional rhythm monitoring may still be indicated and ensure that the monitoring and follow-up plan are clearly documented.
Common pitfall: A single normal ECG cannot exclude intermittent atrial fibrillation. An embolic-looking infarct also does not by itself prove atrial fibrillation or justify empiric anticoagulation.
Top Things to Know: 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Guideline · Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke
22.What distinguishes intracerebral from subarachnoid hemorrhage?
Intracerebral hemorrhage is bleeding into brain parenchyma; subarachnoid hemorrhage is bleeding into the space around the brain where cerebrospinal fluid circulates. Imaging identifies the compartment and distribution, which directs investigation of the bleeding source and anticipated complications. Severe headache or reduced consciousness can occur in more than one hemorrhage type, so symptoms alone cannot reliably establish the compartment. Aneurysmal subarachnoid hemorrhage particularly requires identification and treatment of the responsible aneurysm.
Apply it
One scan shows a deep parenchymal hematoma, while another shows blood in the basal cisterns. Use the imaging distinction to anticipate different vascular investigations and management pathways instead of grouping both under an undifferentiated hemorrhagic stroke label.
Common pitfall: A dramatic headache does not establish aneurysmal subarachnoid hemorrhage without diagnostic evaluation. Hemorrhage location and cause must be distinguished before assuming an identical treatment plan.
Emergency Management of Intracerebral Hemorrhage · Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
Acute Neurovascular Management14%
23.How do disability and the standard thrombolysis window guide assessment?
The standard intravenous thrombolysis window is within 4.5 hours of known symptom onset, using last-known-well when appropriate to the onset history. Eligible patients with disabling ischemic deficits need rapid assessment even when the NIHSS total is low. Aphasia or loss of useful hand function may prevent essential activities despite a small score. Brain imaging must exclude hemorrhage and essential contraindications must be assessed, but unnecessary advanced imaging should not delay otherwise indicated treatment within this window. Selected extended-window pathways use additional criteria.
Apply it
Two hours after witnessed onset, a previously independent patient has disabling aphasia with little weakness. Report the functional loss and exact onset, complete essential safety checks and support prompt treatment assessment without waiting for a higher score or perfusion imaging.
Common pitfall: A low NIHSS does not establish a nondisabling event. The 4.5-hour boundary is also not permission to delay: eligible patients should be treated as quickly as possible.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
24.What immediate surveillance is required after intravenous thrombolysis?
Beginning with intravenous thrombolytic administration, perform blood pressure and neurological assessments every 15 minutes for the first 2 hours, every 30 minutes for the next 6 hours, then hourly until 24 hours. Maintain blood pressure below 180/105 mm Hg for at least the first 24 hours; readings outside this target require prompt reassessment, increased monitoring and prescribed antihypertensive treatment. These parameters are specified in the [2026 AHA/ASA guideline, section 4.3 and Table 7](https://www.ahajournals.org/doi/10.1161/STR.0000000000000513). Compare alertness, pupils, language and limb findings with baseline. Inspect puncture sites for bleeding and assess for tongue or lip swelling, stridor and respiratory difficulty. New severe headache, vomiting, acute hypertension or neurological deterioration requires immediate assessment for possible intracranial hemorrhage regardless of the scheduled observation time. Stop an ongoing alteplase infusion, notify the stroke team immediately and obtain emergency head CT; support airway and circulation and prepare urgent laboratory testing and hemorrhage treatment. Tenecteplase is administered as a bolus, so there is no ongoing infusion to stop.
Apply it
Three hours after thrombolysis begins, a stable patient requires assessments every 30 minutes. A blood pressure of 190/110 mm Hg exceeds the treatment target and requires increased monitoring and prescribed treatment. If severe headache, vomiting or worsening weakness appears between observations, assess immediately and activate the emergency response for suspected intracranial bleeding; do not wait for the next scheduled check.
Common pitfall: The observation schedule defines routine surveillance, not a waiting period when symptoms change. Early improvement does not justify reducing monitoring. Do not attribute deterioration automatically to the original infarct, and do not confuse the blood pressure criteria used before thrombolysis with the maintenance target required during the first 24 hours.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS · Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke
25.How do imaging criteria distinguish selected extended thrombolysis pathways?
For unknown-onset stroke, the DWI–FLAIR pathway requires treatment within 4.5 hours of symptom recognition, an MRI-DWI lesion smaller than one-third of the middle cerebral artery territory and no marked corresponding FLAIR signal change. This mismatch estimates lesion recency. The separate perfusion-selected recommendation concerns patients ineligible for thrombectomy who are 4.5–9 hours from last-known-well or awaken with symptoms within nine hours of the midpoint of sleep. Automated perfusion imaging must identify salvageable tissue. EXTEND-derived selection criteria are core below 70 mL, hypoperfused-to-core volume ratio above 1.2 and mismatch volume above 10 mL; hypoperfusion uses Tmax above six seconds, while core uses DWI or relative cerebral blood flow below 30%. These extended-window intravenous thrombolysis pathways must not replace or delay indicated thrombectomy. See [2026 guideline, section 4.6.3](https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000513) and [formal correction, item 13](https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000530?download=true).
Apply it
A patient awakens with aphasia. Preserve last-known-well and discovery times. For DWI–FLAIR selection, communicate lesion extent and recognition-to-treatment time. For perfusion selection, communicate the EXTEND-derived profile, relevant time boundary and thrombectomy ineligibility; expedite thrombectomy when indicated.
Common pitfall: DWI–FLAIR mismatch and perfusion mismatch answer different questions. A favorable mismatch alone does not establish eligibility; lesion size, timing, contraindications and the applicable thrombectomy boundary still matter.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
26.When is an intensive systolic target below 140 harmful after thrombectomy?
For patients with anterior-circulation large-vessel occlusion who achieve successful recanalization after thrombectomy, an intensive systolic treatment target below 140 mm Hg during the first 72 hours is harmful and not recommended when there is no other indication for a different blood pressure target. Excessive lowering can compromise perfusion in vulnerable tissue despite restored large-artery flow. Continue serial neurological and pressure assessment while implementing the appropriate prescribed range. This recommendation concerns an active intensive-lowering strategy; a spontaneous reading below 140 does not by itself establish treatment-induced harm or require pressure augmentation.
Apply it
Twelve hours after successful recanalization of an anterior-circulation occlusion, an order proposes actively lowering systolic pressure to 120–130 solely to improve stroke outcome. Clarify the order and whether any separate condition requires a different target.
Common pitfall: Extending this recommendation indefinitely or to every thrombectomy population loses its clinical boundaries. A spontaneous lower reading requires assessment of trend and clinical status, not automatic vasopressor treatment.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
27.What is nimodipine intended to improve after aneurysmal SAH?
Early enteral nimodipine after aneurysmal subarachnoid hemorrhage improves functional outcomes and helps prevent delayed cerebral ischemia. Its purpose should be distinguished from securing the ruptured aneurysm or treating every angiographic narrowing directly. Monitor administration continuity and hemodynamic tolerance, and escalate barriers to the treating team. New neurological decline still requires investigation because delayed cerebral ischemia, hydrocephalus, rebleeding and other complications can overlap clinically despite preventive treatment.
Apply it
A patient with aneurysmal subarachnoid hemorrhage has enteral nimodipine prescribed. The nurse verifies reliable delivery, monitors blood pressure and reports a new focal deficit rather than assuming preventive therapy excludes delayed cerebral ischemia.
Common pitfall: Nimodipine does not seal the aneurysm or eliminate the need to investigate deterioration. Equating its benefit solely with reversal of visible vasospasm oversimplifies its role.
Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
28.Why secure a ruptured cerebral aneurysm promptly?
An unsecured ruptured aneurysm remains a source of potentially devastating rebleeding. Early evaluation and treatment, preferably within 24 hours when feasible, aim to exclude the aneurysm from the circulation through an appropriate endovascular or surgical approach. Selection depends on aneurysm and patient factors assessed by an experienced team. Nursing care supports timely transfer, physiological stability and recognition of deterioration while distinguishing aneurysm treatment from later prevention and management of delayed cerebral ischemia.
Apply it
A patient with confirmed aneurysmal subarachnoid hemorrhage is at a hospital without definitive treatment capability. The nurse supports urgent specialist transfer and communicates imaging, neurological status and current therapies to reduce delays in securing the aneurysm.
Common pitfall: Improvement in headache does not establish that rebleeding risk has resolved. Nimodipine and observation do not replace definitive evaluation and treatment of the ruptured aneurysm.
Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
29.Which reversal principle applies to dabigatran-associated ICH?
Anticoagulant-associated intracerebral hemorrhage requires urgent identification of the anticoagulant and rapid reversal when indicated. Idarucizumab specifically reverses dabigatran, a direct thrombin inhibitor. Vitamin K addresses vitamin K antagonist effects and is not a substitute for dabigatran-specific reversal. The nurse rapidly communicates drug identity, last dose and relevant renal information, supports emergency orders and monitors neurological status. Reversal selection follows the actual drug rather than the general label of anticoagulation.
Apply it
A patient with an expanding intracerebral hemorrhage took dabigatran earlier that day. The nurse highlights the medication and timing during emergency escalation and prepares the prescribed drug-specific reversal pathway rather than a warfarin-focused intervention.
Common pitfall: Assuming one reversal agent treats every anticoagulant can delay effective care. A routine INR is not a reliable measure of the full dabigatran anticoagulant effect.
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage
30.How should blood pressure lowering be approached in selected ICH?
For selected patients with mild to moderate spontaneous intracerebral hemorrhage and presenting systolic pressure of 150–220 mm Hg, targeting 140 and maintaining 130–150 mm Hg is considered safe and may be reasonable. Smooth, sustained control limits large fluctuations; lowering below 130 may be harmful. These criteria do not establish a universal target for severe hemorrhage or every clinical circumstance. Monitor pressure and neurological findings together while implementing the individualized treatment order.
Apply it
A patient with a mild to moderate spontaneous hematoma presents with systolic pressure of 185 mm Hg. During prescribed lowering, the nurse tracks variability and alerts the team if pressure approaches an excessively low range or neurological findings worsen.
Common pitfall: Applying the same target to every hemorrhage ignores severity and clinical context. Rapid overshoot below the recommended maintenance range is not evidence of better control.
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage
Pathophysiology & Pathogenesis of Neurovascular Disease14%
31.What distinguishes thrombosis from embolism?
Thrombosis is clot formation at the site where it obstructs blood flow. Embolism occurs when material travels from another location and lodges in a downstream vessel. Both can interrupt cerebral perfusion, but the source investigation differs. Local arterial disease may support thrombosis, whereas a cardiac source or proximal arterial plaque may generate emboli. Identifying the mechanism informs prevention; the shared outcome of ischemia does not make all antithrombotic strategies interchangeable.
Apply it
Compare a clot forming over a diseased cerebral artery with a clot traveling from the left atrium into a cerebral artery. Explain why both cause ischemia but lead the team to investigate different sources and prevention strategies.
Common pitfall: An embolus does not have to originate in the heart. Proximal arterial plaque can also release material that obstructs a more distal cerebral vessel.
32.How can atrial fibrillation produce cerebral embolism?
Disorganized atrial activation reduces effective contraction and promotes blood stasis, allowing thrombus formation within the atrium, particularly the left atrial appendage. A fragment can enter the systemic circulation and obstruct a cerebral artery. This mechanism explains why atrial fibrillation changes secondary prevention decisions. The arrhythmia may be intermittent, so its causal evaluation is not limited to whether an irregular rhythm is present during a single bedside examination or brief ECG recording.
Apply it
A patient with intermittent atrial fibrillation has an ischemic stroke. Explain how a clot can form during atrial stasis and later embolize, even when the rhythm is regular during the current neurological assessment.
Common pitfall: A regular pulse today does not exclude an earlier cardioembolic mechanism. Conversely, every ischemic stroke in a patient with atrial fibrillation still deserves mechanism-focused evaluation.
Stroke: Causes and Risk Factors · Top Things to Know: 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Guideline
33.Why can atherosclerotic plaque cause stroke without complete local blockage?
Atherosclerosis narrows and damages arterial walls, providing a surface for thrombus formation. Plaque-associated material or clot can detach and embolize to a smaller downstream artery. Thus, a proximal artery need not be completely occluded to produce cerebral ischemia. Reduced flow and local thrombosis are additional mechanisms. This distinction helps connect carotid or intracranial arterial disease with a distal infarct and explains why vascular imaging evaluates more than the final obstructed vessel.
Apply it
A patient has a distal cerebral infarct and an ipsilateral diseased carotid artery that remains patent. Explain how artery-to-artery embolization can connect the proximal plaque to the distal injury without requiring complete carotid occlusion.
Common pitfall: Calling a patent artery harmless overlooks plaque-related embolization. The presence of plaque alone also does not prove causation without considering lesion territory and competing sources.
34.How does small-vessel disease differ from large-artery disease?
Small-vessel disease affects the penetrating arteries supplying deep brain structures, whereas large-artery disease involves major extracranial or intracranial vessels. Chronic hypertension can damage small arterial walls and contribute to deep ischemic injury or hemorrhage. A small deep infarct therefore suggests a different mechanism from an embolus lodging in a major cortical artery, although imaging pattern alone is not conclusive. Mechanism assessment integrates lesion location, vascular findings, rhythm evaluation and vascular risk factors.
Apply it
A patient with longstanding hypertension has a small deep infarct and no major arterial occlusion. Discuss small-vessel disease as a plausible mechanism while supporting the remaining evaluation rather than assuming every ischemic event originates in the heart.
Common pitfall: Small lesion size does not automatically mean low functional impact. A strategically located deep lesion can cause substantial weakness despite occupying a limited volume.
35.What makes cerebral amyloid angiopathy a cause of lobar hemorrhage?
Cerebral amyloid angiopathy involves amyloid deposition in small cortical and leptomeningeal vessel walls, increasing their fragility. It is an important cause of lobar intracerebral hemorrhage, especially in older adults, and can influence recurrence risk and antithrombotic decisions. This distribution differs from the deep hemorrhage pattern commonly associated with hypertensive arteriopathy. Location and MRI markers inform the evaluation, but age or a single lobar bleed alone does not establish a definitive etiologic diagnosis.
Apply it
An older adult has recurrent lobar hemorrhages without a deep hematoma pattern. Explain why the team considers cerebral amyloid angiopathy and reviews hemorrhage-sensitive MRI findings before weighing future antithrombotic risks and benefits.
Common pitfall: Attributing every intracerebral hemorrhage to hypertension overlooks other vascular pathologies. Lobar location suggests an etiologic investigation rather than proving cerebral amyloid angiopathy by itself.
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage
36.How does an aneurysm cause subarachnoid hemorrhage?
A cerebral aneurysm is a focal abnormal dilation of an artery. Rupture can release arterial blood into the subarachnoid space, abruptly exposing surrounding structures to blood and increased intracranial pressure. The ruptured vessel remains a rebleeding source until effectively treated. The presence of an unruptured aneurysm is different from confirmed aneurysmal hemorrhage, so imaging must establish both the bleeding pattern and the likely culprit lesion before treatment planning.
Apply it
A patient has sudden severe headache, subarachnoid blood on CT and an aneurysm on arterial imaging. Connect the bleeding compartment with arterial rupture and explain why the team prioritizes identifying and securing the responsible aneurysm.
Common pitfall: An aneurysm found incidentally does not prove it caused the current symptoms. Conversely, aneurysmal hemorrhage involves more than headache severity and requires urgent diagnostic confirmation.
Stroke: Causes and Risk Factors · Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
37.Why can an arteriovenous malformation bleed?
An arteriovenous malformation is an abnormal connection between arteries and veins that bypasses the usual capillary network. Abnormal vessels and altered flow create a potential source of intracranial hemorrhage. This is structurally different from a focal arterial aneurysm and from hypertensive small-vessel disease. Recognizing a possible vascular malformation prompts targeted vascular evaluation; the treatment decision depends on the lesion's anatomy, presentation and specialist assessment rather than the generic diagnosis of hemorrhagic stroke.
Apply it
A younger patient has an intracerebral hemorrhage without an established hypertensive explanation. Explain why vascular imaging may investigate an arteriovenous malformation and why its abnormal arterial-to-venous connections require anatomical characterization.
Common pitfall: Using aneurysm and arteriovenous malformation as synonyms obscures different vascular structures. Patient age can guide suspicion but cannot establish or exclude either diagnosis on its own.
38.Why does hemorrhage injure tissue beyond the initial bleeding site?
Intracerebral blood directly disrupts tissue, but injury can evolve through hematoma expansion, surrounding edema, mass effect and extension into the ventricles. Ventricular blood may obstruct cerebrospinal fluid flow and produce hydrocephalus. These processes explain why a patient can deteriorate after an initially stable examination. Serial neurological assessment is therefore a physiological surveillance tool: new consciousness changes or focal findings may signal an evolving structural complication rather than simply the fixed effect of the original bleed.
Apply it
A patient with an initially small hematoma later becomes less responsive. Explain how expansion, swelling or impaired cerebrospinal fluid circulation can create new injury and why the original scan cannot fully describe the current intracranial state.
Common pitfall: Assuming hemorrhage severity is fixed at the first scan overlooks secondary injury. A stable initial hematoma size does not eliminate later edema or hydrocephalus risk.
Emergency Management of Intracerebral Hemorrhage · 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage
Secondary Stroke Prevention10%
39.Which prevention strategy addresses atrial fibrillation after ischemic stroke?
For most patients with ischemic stroke and atrial fibrillation, anticoagulation is the mechanism-directed antithrombotic strategy when there is no contraindication. Antiplatelet therapy is not an equivalent substitute for preventing atrial fibrillation-related embolism. Initiation timing and agent selection require assessment of infarct characteristics, bleeding risk and other clinical factors. Nursing education should clarify the indication, adherence, bleeding precautions and follow-up rather than implying that every stroke survivor should receive the same antithrombotic regimen.
Apply it
A patient with confirmed atrial fibrillation asks whether aspirin provides the same protection as the prescribed anticoagulant. Explain the different mechanism and reinforce the individualized start date, adherence plan and instructions for reporting bleeding.
Common pitfall: Adding aspirin routinely to anticoagulation can increase bleeding without an established stroke-prevention indication. Combination therapy requires a separate clinical reason and a deliberate treatment plan.
40.Which patients qualify for a 21-day aspirin–clopidogrel course?
Canadian guidance recommends aspirin 81 mg daily plus clopidogrel 75 mg daily for 21 days after acute minor noncardioembolic ischemic stroke with NIHSS 0–3 or a high-risk TIA, when bleeding risk is low, followed by antiplatelet monotherapy. The supporting CHANCE and POINT trial definition of high-risk TIA used ABCD2 at least 4; that score supports treatment selection but does not replace urgent diagnostic assessment. Prescribed loading doses precede maintenance therapy. Longer combination treatment requires a distinct indication, such as selected severe symptomatic intracranial stenosis or an arterial stent. After intravenous thrombolysis, antiplatelets are generally withheld for the first 24 hours and started only after follow-up imaging excludes hemorrhage.
Apply it
A patient with a noncardioembolic stroke, NIHSS 2 and low bleeding risk receives a 21-day aspirin–clopidogrel plan. Confirm the start and stop dates, the subsequent single agent and any thrombolysis-related delay before the first antiplatelet dose.
Common pitfall: NIHSS 0–3 defines the minor-stroke population for this regimen, not eligibility for every stroke treatment. Symptom resolution does not justify stopping prevention, and tolerating dual therapy does not justify extending it.
6. Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack | Canadian Stroke Best Practices · Top Things to Know: 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Guideline
41.How does severe symptomatic intracranial stenosis change the antiplatelet course?
For a recent stroke or TIA attributable to 70–99% intracranial atherosclerotic stenosis, Canadian guidance supports considering the SAMMPRIS medical regimen when bleeding risk is low: aspirin plus clopidogrel for the first three months, typically followed by antiplatelet monotherapy. This is a distinct indication from the common 21-day course for qualifying minor stroke or high-risk TIA. Intensive lipid lowering, blood pressure treatment and structured lifestyle modification accompany antiplatelet therapy. Intracranial angioplasty or stenting is not the routine first-line prevention strategy.
Apply it
A recent territorial stroke is attributed to 80% intracranial stenosis. Explain why the prescribed three-month combination course differs from a relative's 21-day minor-stroke regimen, and reinforce lipid, pressure and lifestyle treatment alongside it.
Common pitfall: Incidental stenosis does not establish the symptomatic indication. Extending combination therapy indefinitely or substituting immediate routine intracranial stenting misapplies the evidence.
6. Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack | Canadian Stroke Best Practices · Top Things to Know: 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Guideline
42.How should vascular risk reduction be individualized after stroke?
Secondary prevention addresses modifiable contributors such as hypertension, dyslipidemia, diabetes, smoking, physical inactivity and dietary patterns. These measures complement the mechanism-specific antithrombotic or vascular plan rather than replacing it. Effective nursing education connects each action to a feasible routine and checks barriers such as cost, swallowing difficulty or limited mobility. A recurrent event despite a prescription should prompt assessment of adherence and risk-factor control before assuming the medicine itself has failed.
Apply it
A patient reports taking preventive medicines only when feeling unwell. Review the purpose of daily therapy, identify an affordable reminder system and coordinate a safe activity and nutrition plan suited to the patient's residual deficits.
Common pitfall: Providing a generic lifestyle leaflet without checking practical barriers may not change risk. Feeling well does not indicate that hypertension, dyslipidemia or embolic risk has resolved.
43.Which symptomatic extracranial carotid stenoses warrant early intervention assessment?
Recent TIA or nondisabling ischemic stroke attributable to ipsilateral extracranial carotid stenosis of 70–99% is a strong indication for carotid endarterectomy assessment when expected perioperative stroke and death risk is below 6% and the patient is otherwise suitable. When revascularization is indicated, it is generally considered within two weeks of the event. Selected patients with 50–69% symptomatic stenosis may benefit after assessment of age, sex, comorbidities and procedural risk; stenosis below 50% does not support carotid revascularization for this indication. Anatomy, disability and patient factors also guide endarterectomy versus stenting.
Apply it
A patient has a nondisabling left hemispheric stroke and 80% left extracranial carotid stenosis. Support urgent vascular assessment aimed at an appropriate intervention within two weeks, while continuing prescribed medical prevention and assessing procedural suitability.
Common pitfall: Any plaque is not enough: symptom attribution and measured severity matter. The strong severe-stenosis indication must not be extended automatically to moderate disease, stenosis below 50% or intracranial lesions.
44.Why avoid empiric anticoagulation for an unexplained embolic stroke?
An embolic stroke of undetermined source does not establish atrial fibrillation or another indication for anticoagulation. The prevention guideline advises against empiric anticoagulation for this category because presumed embolic appearance alone has not established benefit from that strategy. Continue a mechanism-focused investigation, including appropriate rhythm assessment, and use the prevention plan supported by the findings. Diagnostic uncertainty should lead to targeted evaluation rather than automatic escalation to a treatment with additional bleeding risk.
Apply it
A patient has an embolic-appearing infarct but no identified cardiac source or atrial fibrillation. Explain why the team arranges further investigation instead of choosing anticoagulation solely from the appearance of the brain lesion.
Common pitfall: Embolic-looking does not mean proven cardioembolic. Conversely, failure to find atrial fibrillation on one brief recording does not end an otherwise indicated rhythm investigation.
Complication Avoidance & Management9%
45.When must swallowing be screened after stroke?
A validated swallowing screen should occur before oral food, fluids or medicines after acute stroke. Dysphagia may impair airway protection even when the patient is alert and can speak. Screening identifies patients who need further assessment; it is not equivalent to a detailed swallowing evaluation. Until safety is established, use the prescribed nonoral care and medication plan. Clear communication of swallowing status prevents an otherwise routine drink or tablet from creating an avoidable aspiration exposure.
Apply it
An alert patient requests water to take a home tablet shortly after admission for stroke. The nurse checks that a validated swallowing screen has been completed and follows the nonoral plan while swallowing safety remains unestablished.
Common pitfall: Normal conversation and an intact gag response do not establish safe swallowing. Giving a small test sip outside the validated pathway can itself expose the patient to aspiration.
46.What follows a failed stroke swallowing screen?
A failed swallowing screen calls for prompt referral for comprehensive swallowing assessment and an interim plan that avoids unsafe oral intake. Assessment determines appropriate textures, strategies and whether instrumental evaluation is needed. Nutrition, hydration and medication delivery still require active planning rather than indefinite omission. The nurse communicates restrictions across handovers and coordinates the prescribed alternative routes. Absence of coughing during a later casual sip does not overturn a failed validated screen.
Apply it
A patient coughs and develops a wet voice during the validated screen. Stop oral intake according to the pathway, document the failure, request swallowing assessment and clarify how essential medicines, hydration and nutrition will be provided.
Common pitfall: Independently substituting thickened fluids after a failed screen bypasses individualized assessment. Keeping a patient without an active hydration or medication plan creates a different set of preventable harms.
47.Why does oral hygiene matter when a patient is not eating?
Patients can aspirate colonized oral secretions even when food and drink are withheld. Regular, effective oral hygiene reduces the burden of oral debris and microorganisms and supports comfort and oral health. It therefore remains important for patients with dysphagia or enteral feeding. Adapt the technique to consciousness, airway protection and assistance needs, using the institution's safe oral care process. A feeding tube changes nutrition delivery but does not eliminate aspiration of secretions.
Apply it
A dysphagic patient receives tube feeding and remains without oral food or fluids. Include assisted oral care in the nursing plan, using appropriate positioning and secretion management rather than omitting mouth care because meals are not being served.
Common pitfall: Tube feeding does not make oral hygiene unnecessary or remove all aspiration risk. Mouth care should also avoid introducing excessive fluid into an unprotected airway.
48.Which mechanical VTE prevention is supported after nonambulatory ICH?
Intermittent pneumatic compression beginning on the day of diagnosis is recommended for nonambulatory patients with spontaneous intracerebral hemorrhage. It reduces venous stasis without requiring immediate systemic anticoagulation. Graduated compression stockings alone do not provide equivalent benefit in this setting. Pharmacological prophylaxis is a separate decision that considers timing and hemorrhage stability. Nursing care includes correct device use, skin assessment and attention to interruptions so that an ordered device delivers the intended protection.
Apply it
A nonambulatory patient with acute intracerebral hemorrhage has pneumatic compression ordered. Apply and maintain the device as prescribed, check skin and fit, and clarify a stocking-only substitution rather than assuming all compression methods are equivalent.
Common pitfall: Elastic stockings alone are not an evidence-equivalent substitute for intermittent pneumatic compression. The bleeding diagnosis also does not justify leaving venous thrombosis prevention entirely unaddressed during immobility.
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage
49.Why review urinary catheter necessity every day?
Indwelling urinary catheters increase infection risk and can impede mobility, so their indication should be reviewed regularly and removal pursued when no longer needed. Incontinence alone does not establish a continuing indication. Stroke-related bladder problems require assessment for retention, functional barriers and an appropriate continence plan. Nursing alternatives can include assisted toileting and other prescribed strategies. Distinguish a genuine need for catheterization from convenience, while avoiding premature removal when a documented clinical indication persists.
Apply it
A catheter inserted during emergency care remains in place after the patient stabilizes. The nurse checks the current indication, assesses bladder function and mobility, and initiates the approved removal and toileting pathway when continued catheterization is unnecessary.
Common pitfall: Keeping a catheter solely to simplify incontinence care exposes the patient to avoidable harm. Removing one without assessing retention or the ongoing indication is also incomplete care.
Inpatient Prevention and Management of Complications following Stroke
50.How should early mobility be balanced with acute stroke stability?
Mobility planning should consider neurological stability, physiological tolerance, assistance needs and treatment restrictions. Safe progressive activity helps address immobility, but very early high-intensity mobilization is not a universal goal and can be harmful in selected acute stroke settings. After intracerebral hemorrhage, guidance distinguishes appropriately timed rehabilitation from aggressive mobilization during the first 24 hours. Coordinate the plan with the stroke and rehabilitation teams, and reassess symptoms rather than equating more activity with better care.
Apply it
Soon after intracerebral hemorrhage, a weak patient is proposed for repeated intensive out-of-bed sessions. The nurse checks timing, stability and the rehabilitation plan, then supports appropriately paced activity with monitoring and sufficient assistance.
Common pitfall: Avoiding all movement indefinitely and pursuing aggressive activity immediately are both poor shortcuts. Timing, intensity and patient stability determine whether a mobility plan is appropriate.
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage · Inpatient Prevention and Management of Complications following Stroke
Research Support for Acute Neurovascular Practice9%
51.Why does randomization strengthen a treatment comparison?
Randomization assigns participants to comparison groups by chance, reducing systematic differences in both known and unknown prognostic factors on average. It supports causal interpretation when combined with sound trial conduct, but it does not guarantee identical groups in a particular study. Random allocation differs from random sampling, which concerns selection into a study population. Examine allocation methods and concealment, baseline characteristics and follow-up rather than assuming the word randomized eliminates every important source of bias.
Apply it
A stroke nursing trial allocates participants by a computer-generated sequence rather than clinician preference. Explain how this limits systematic treatment selection while still checking whether allocation was concealed and whether outcome follow-up was adequate.
Common pitfall: Alternating patients between groups is predictable and is not equivalent to randomization. Random assignment also does not by itself establish that the participants represent every clinical population.
Clinical Trials: How Clinical Trials Work · Study Quality Assessment Tools
52.How do blinding and allocation concealment prevent different biases?
Allocation concealment prevents those enrolling participants from knowing the upcoming assignment, protecting group formation before treatment allocation. Blinding limits knowledge of assigned treatment afterward and can reduce differences in care, reporting or outcome assessment. A trial can achieve one without the other. In a nursing intervention that cannot blind staff or patients, blinded outcome assessment may still be feasible. Identify who was blinded and at what stage rather than accepting an unexplained label.
Apply it
Staff cannot be blinded to a bedside education intervention, but independent assessors do not know group assignment. Recognize the value of blinded outcome assessment while separately checking whether enrollment staff could predict the next treatment allocation.
Common pitfall: Calling a study blinded does not establish concealed enrollment. Likewise, an intervention that cannot blind participants may still reduce detection bias through independent blinded outcome assessment.
Clinical Trials: How Clinical Trials Work · Study Quality Assessment Tools
53.Why analyze randomized participants in their assigned groups?
Intention-to-treat analysis compares participants according to their original randomized groups, regardless of subsequent adherence or crossover. This helps preserve the balance created by randomization and avoids selectively removing participants whose prognosis may differ. It estimates the effect of assignment under the trial's conditions rather than the effect only among perfect adherers. Missing outcome data remain a threat and require scrutiny; labeling an analysis intention-to-treat does not make unavailable outcomes disappear.
Apply it
Several participants assigned to a new prevention program stop attending after complications. In appraising the trial, check whether their outcomes remain associated with the assigned group rather than being excluded to create a more favorable comparison.
Common pitfall: Removing nonadherent participants can destroy the randomized comparison. Intention-to-treat also does not justify ignoring extensive missing data or assuming that all missing outcomes were favorable.
54.How is absolute risk reduction calculated?
For an undesirable outcome, absolute risk reduction is the control event risk minus the intervention event risk over the same follow-up period. If risks are 12% and 8%, the absolute reduction is four percentage points, or 0.04. Relative risk reduction instead divides that difference by the control risk. Reporting both helps distinguish proportional benefit from the number of events affected in practice. Interpretation also requires the outcome definition, baseline risk and uncertainty.
Apply it
In a fictional one-year trial, recurrent events occur in 60 of 500 controls and 40 of 500 intervention participants. Calculate risks of 12% and 8%, then report a four-percentage-point absolute reduction for that outcome.
Common pitfall: Subtracting percentages gives percentage points, not a relative percentage reduction. Comparing event proportions from unequal follow-up periods can also make the apparent absolute benefit misleading.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
55.What does a number needed to treat actually describe?
For a beneficial reduction in an adverse outcome, number needed to treat is the reciprocal of absolute risk reduction expressed as a proportion. An absolute reduction of 0.04 gives an NNT of 25. Round a noninteger result upward to the next whole person. State the outcome and follow-up duration because NNT changes with baseline risk and time. It is a group-level estimate, not a promise that a particular numbered patient will benefit.
Apply it
A fictional trial reports an adverse outcome in 10% of controls and 7% of treated participants over one year. The absolute reduction is 0.03, so the reciprocal is 33.3 and the one-year NNT is 34.
Common pitfall: Using three instead of 0.03 in the reciprocal gives an invalid result. An NNT without an outcome, time horizon or relevant baseline risk is incomplete.
Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
Stroke Systems of Care7.5%
56.Why does EMS stroke prenotification improve readiness?
Prenotification allows the receiving hospital to prepare its stroke team, imaging resources and immediate assessment pathway before arrival. Its value comes from actionable information: suspected stroke findings, last-known-well, discovery time, glucose, relevant medicines and estimated arrival. The message supports preparation rather than establishing a final diagnosis or guaranteeing treatment. Effective nursing reception converts the alert into timely coordinated actions while preserving the need to confirm the history, examination and imaging.
Apply it
EMS reports sudden aphasia, a known last-well time, normal glucose and an estimated arrival. The receiving nurse activates the local stroke response and prepares the assessment route so essential work can begin promptly on arrival.
Common pitfall: An alert that only says possible stroke omits information needed for preparation. Prenotification also does not replace bedside reassessment or establish reperfusion eligibility by itself.
Emergency Medical Services Management of Acute Stroke Patients
57.How should prehospital destination decisions support stroke treatment?
Destination planning balances rapid access to stroke assessment with access to the capabilities a patient may need, including thrombectomy. Regional protocols consider transport times, suspected severity, hospital resources and transfer arrangements. A prehospital severity screen can support suspected large-vessel occlusion recognition but does not confirm the arterial diagnosis. The nursing systems perspective is to understand the local network and prepare appropriate handoffs, rather than assuming the nearest hospital or most specialized hospital is always the correct destination.
Apply it
EMS suspects a severe stroke in a region with both a nearby stroke hospital and a more distant thrombectomy center. Apply the regional destination pathway using travel and capability information instead of selecting solely by distance.
Common pitfall: A high prehospital severity score is not angiographic proof of occlusion. A universal bypass rule can ignore geography, treatment delays and the capabilities of the regional network.
Emergency Medical Services Management of Acute Stroke Patients
58.Why organize acute stroke work in parallel?
Time-sensitive stroke care benefits when compatible tasks occur concurrently: focused history, neurological examination, glucose testing, vascular access, imaging preparation and team communication. A clear local pathway assigns responsibilities and prevents duplication or avoidable waiting. Parallel work does not mean omitting required checks or allowing contradictory actions. The coordinating nurse identifies dependencies, escalates missing information and ensures that results reach the decision-maker, turning separate tasks into an integrated diagnostic and treatment process.
Apply it
During a stroke activation, one team member verifies last-known-well while another checks glucose and the nurse coordinates transport to imaging. Essential findings are shared immediately rather than waiting for each task to finish before starting the next.
Common pitfall: Performing every task sequentially creates avoidable delay. Uncoordinated simultaneous work can also cause missed checks, so parallel activity still needs assigned roles and shared communication.
59.Which information makes a stroke handover actionable?
A useful stroke handover separates last-known-well from discovery, describes baseline function and current deficits, and communicates glucose, vital signs, anticoagulant identity and timing, imaging and treatments already given. Include changes during transport or observation and identify uncertain facts explicitly. This lets the receiving team continue the decision process without reconstructing the event. A score alone is insufficient because the specific deficit, its functional impact and its evolution may determine the next action.
Apply it
A transferring nurse reports the patient's prior independence, witnessed onset, persistent disabling aphasia, glucose, last anticoagulant dose, scan findings and treatment times. The receiving nurse repeats back uncertain timing information before the transport team leaves.
Common pitfall: A handover limited to stroke score and stable vital signs can omit eligibility-critical facts. Guessing an unknown medication time is more dangerous than clearly labeling uncertainty.
Emergency Medical Services Management of Acute Stroke Patients · Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke
60.How can interfacility transfer preserve treatment continuity?
Transfer for advanced stroke care requires early communication with the receiving service, rapid access to imaging and a clear record of treatment, timing and neurological trajectory. Sending the patient without essential clinical information can create repeat work and delay definitive decisions. Monitoring and escalation responsibilities continue during transfer. The sending nurse confirms that current therapies, airway or hemodynamic concerns, allergies and pending issues are communicated through the regional process rather than assuming the referral call contains everything.
Apply it
A patient with an identified large-vessel occlusion is accepted for thrombectomy assessment elsewhere. The nurse coordinates image availability, treatment records and a structured handover, while documenting the latest examination and arranging the prescribed monitoring during transport.
Common pitfall: Acceptance by a specialist does not complete the transfer process. Missing images, undocumented treatment times or unclear monitoring responsibility can interrupt care despite an appropriate destination.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · Emergency Medical Services Management of Acute Stroke Patients
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Allocate the largest study share to assessment and diagnosis: together they represent 36.5% of the official blueprint.
- Practise standardized NIHSS motor, language, articulation and extinction findings while describing disability beyond the total score.
- Connect each imaging modality to its decision: hemorrhage, arterial obstruction, tissue injury or selected advanced-imaging eligibility.
- Learn the standard 4.5-hour intravenous thrombolysis window, distinguish imaging mismatch pathways and rehearse immediate post-thrombolysis surveillance and response to suspected bleeding.
- Separate ischemic stroke, intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage treatment principles, including the population and time limits of blood pressure recommendations.
- Match secondary prevention to mechanism, distinguishing the 21-day minor-stroke regimen, selected three-month intracranial-stenosis regimen and early symptomatic carotid intervention assessment.
- Rehearse swallowing precautions, pneumatic compression, oral care, catheter review and response to neurological deterioration.
- Calculate absolute risk reduction and NNT with explicit outcomes and time horizons; appraise randomization, blinding and missing data.
- Practise concise stroke handovers that preserve true timing, medication details, functional deficits and changes during care.
A practical preparation plan
1. Map preparation to the official domains
Use the eight published weights to plan study time. Treat the official outline as the full scope and these 60 concepts as a selective foundation. Record weak domains rather than interpreting the short drill as a readiness score.
2. Build an assessment-to-imaging sequence
For each case, state last-known-well, glucose, medication timing, specific neurological findings and disability. Then identify which unanswered question requires noncontrast CT, vascular imaging or MRI.
3. Compare the three acute treatment pathways
Create separate summaries for ischemic stroke, intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage. Define the standard thrombolysis window and selected imaging pathways. Rehearse post-thrombolysis neurological, pressure, bleeding and airway surveillance, including stopping an ongoing alteplase infusion and obtaining emergency CT for suspected intracranial bleeding.
4. Link mechanism, prevention and bedside safety
For each stroke mechanism, explain the prevention rationale and qualifying criteria. Distinguish 21-day and three-month antiplatelet indications and the two-week timing goal for indicated carotid revascularization. Add swallowing, oral care, mobility, VTE and bladder plans.
5. Use the drills for reasoned correction
Answer the 20 questions before reading explanations. For every error, identify the decisive cue and explain why each alternative is weaker. Revisit the corresponding concept and source, then use the flashcard later without looking.
6. Integrate evidence and handover practice
Calculate ARR and NNT from fresh example numbers, then appraise a trial's allocation and analysis methods. Finish with a timed verbal handover that communicates the facts needed for the receiving team's next decision.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- About ANVC
- NVRN certification
- NVC-3
- NVRN Exam Blueprint
- NIH Stroke Scale
- Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke
- Emergency Medical Services Management of Acute Stroke Patients
- Top Things to Know: Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting
- Emergency Management of Intracerebral Hemorrhage
- Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
- Top Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline
- 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage
- Stroke: Causes and Risk Factors
- Top Things to Know: 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Guideline
- Swallowing (Dysphagia), Nutrition and Oral Care
- Inpatient Prevention and Management of Complications following Stroke
- Clinical Trials: How Clinical Trials Work
- Study Quality Assessment Tools
- Cochrane Handbook, Chapter 15: Interpreting results and drawing conclusions
- Atrial Fibrillation - Treatment | NHLBI, NIH
- 6. Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack | Canadian Stroke Best Practices
- Update on the Safety of Andexxa | FDA
- 9. Management of Extracranial Carotid Disease and Intracranial Atherosclerosis | Canadian Stroke Best Practices
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.